Overall, we estimated a total metapopulation within the geographical range of the California brown pelican subspecies (Pelecanus occidentalis californicus) as about 70,680 ± 2,640 breeding pairs (mean ± SD). Little change in at least three decades is indicated in the total metapopulation south of the Southern California Bight (SCB) subpopulation, but significant improve ments in the breeding subpopulation size in the SCB reported elsewhere, support the present high numbers observed in this northernmost subpopulation. The largest breeding aggregation within the entire range (consisting of three immediately adjacent sub-colonies), at the San Lorenzo Archipelago, consisted of about 17,225 breeding pairs, or about 24.4% of the metapopula tion in 2006. Other, smaller colonies are no less important, however, although each subpopulation defined by us seemed to have a single or small number of large "core" breeding colonies, plus many smaller colonies (for example, in 2006, one colony consisted of only 2 breeding pairs). Small colonies (< about 70 nests) comprised about 35.6% of the total occupied colonies, but only about 0.87% of the total estimated numbers (values corrected for detectability). The modal colony-size throughout the range was much smaller (about 230 to 1,300 breeding pairs, depending on subpopulation), indicating that small, scattered colonies and sub-colonies, especially on the range peripheries, function in brown pelican population dynamics and are no less important from a conservation viewpoint. These smaller breeding colonies probably represent some colonies of antiquity, but also range expansions and contractions that occur within the typically-defined metapopulation, and local manifestations of source-sink phenomena. Given such dynamics, even unoccupied islands within the range in 2006 have conservation importance from the viewpoint of such dynamics as potential alternate nesting sites. Natural variations in the estimated population levels seem to be related to the natural cycles of El Niño/Southern Oscillation (ENSO) phenomena where very low breeding popula tions (as low as no nesting in many areas) might be expected to occur in these same areas censused in 2006 at least 40% of the time. From the 2006 aerial survey, extensive commercial and sport-fishing activity, resort/tourist developments and associated human activities along the coastal areas and at offshore islands, and extensive aquacultural (and to a lesser degree, agricultural) developments seen from the Río Colorado Delta region, Sonora, south at least through San Blas, Nayarit (the southern terminus of our 2006 aerial survey) may result in substantial loss of breeding habitat. Juvenile (young of the 2005 breeding season) plus subadult brown pelicans comprised 28.1% ± 0.33% (mean ± 95% CI) of the total numbers in age-ratio samples. Thus, our over all metapopulation estimate for P. o. californicus in 2006 was 195,900 ± 7,225 individuals.

Alo vera is a centenary remedy use for minor wounds and burns, but its mechanism of wound healing has not been know since. This article will evaluate and gather evidence of the effectiveness and safety of the use of aloe vera in the treatment of burns. A systematic review was carried out on the databases: MEDLINE, LILACS, DECS, SCIELO, in the last 7 years, with the descriptors: “Aloe”, “Burns” and “treatment”. 16 articles were found. After using the exclusion criteria; research in non-humans and literature review; 5 articles were selected. The article Teplick et al. (2018) performed an in vitro clinical experiment in A. Vera solution, and demonstrated that there was proliferation and cell migration of human skin fibroblasts and keratinocytes, in addition to being protective in the death of keratonocytes. That is, it accelerates the healing of wounds. Muangman et al. (2016), evaluated 50 patients with 20% of the total body surface area burned with second-degree burns, between 18-60 years old, with half of the group receiving gauze dressings with soft paraffin containing 0.5% chlorhexidine acetate and the other half receiving polyester dressings containing extracts of medicinal plants mainly Aloe Vera. It had positive results, a higher healing speed and shorter hospital stay compared to the control group. Hwang et al. (2015) investigated the antioxidant effects of different extracts from 2,4,6,8,12 months of Aloe Vera. And the 6-month concentrated extract of 0.25 mg / mL had a higher content of flavonoids (9.750 mg catechin equivalent / g extract) and polyphenols (23.375 mg gallic acid equivalent / g extract) and the greater ferric reducing antioxidant power (0.047 mM equivalent ferrous sulfate / mg extract), that is, greater potential for free radical scavenging and also a protective effect against oxidative stress induced by tert-butyl hydroperoxide (t-BHP), suggesting evidence of a bioactive potential of A. vera . However, in the article Kolacz et al. (2014) suggested as an alternative treatment the use of Aloe Vera dressing in combination with honey, lanolin, olive oil, wheat germ oil, marshmallow root, wormwood, comfrey root, white oak bark, lobelia inflata, glycerin vegetable oil, beeswax and myrrh, without obtaining significant and conclusive results that would allow the conventional treatment of burns to be subsidized. Finally, in the article by Zurita and Gallegos (2017), it carried out a descriptive cross-sectional study with 321 people, both sexes between 17-76 years of age, of an inductive nature, exploring the experience of this population and their behavioral attitudes regarding the treatment of dermatoses. Aloe vera had 13.8% cited by individuals in the treatment of acne and 33.6% in the treatment of burns. Even with evidence that suggests the efficacy in the treatment of burns with the use of Aloe Vera extract, further clinical trials with larger sample space on the use of Aloe vera dressings in medium burns are suggested for further conclusions.

No abstract

116 Background: To determine the dosimetric characteristics and risk of breast fibrosis using a normal tissue complication probability (NTCP) model in conjunction with a novel preoperative stereotactic radiotherapy system called the GammaPod. Results are compared with linac based post-lumpectomy APBI plans for the same cohort. Methods: The GammaPod breast SBRT system consists of a Co-60 irradiation unit in combination with an immobilization device with embedded fiducials. Eight patients were enrolled in an IRB-approved protocol and underwent CT scans in the prone position with breast immobilization. A preoperative target (GTV) was synthesized to match the tumor location and volume reported in imaging studies obtained prior to surgery (0.3-2.4 cc). The GTV was expanded by 1.5 cm to create a CTV, and a PTV was created using an additional 0.3 cm margin. The PTV was prescribed 25.5 Gy in 3 fx, which is radiobiologically equivalent to conventional APBI doses of 38.5 Gy in 10 fx. Following the radioablative experience in NSCLC, we also planned to deliver 60.0 Gy to the GTV+0.3 cm as a simultaneous boost in conjunction with the 25.5 Gy PTV prescription dose. For comparison, linac-based treatment plans were created for the same cohort following NSABP B-39 guidelines. Whole breast dosimetry was analyzed in terms of biologically equivalent dose (BED) and Lyman NTCP analysis was performed. Results: The volume of ipsilateral breast receiving 10, 20, 50, and 100% of the prescribed dose was substantially smaller in GammaPod vs. APBI plans, with cohort averages of 19.3, 13.0, 7.1 and 4.0% vs. 75.8, 67.3, 48.1 and 27.6% respectively (p<0.001). Even though the PTV equivalent uniform BED (EUD) was substantially higher in GammaPod plans (87.9 Gy vs. 57.3 Gy), the ipsilateral breast EUD was still smaller in these plans, 18.9 ± 5.0 Gy vs. 47.2 ± 3.2 Gy (p<0.001). Corresponding NTCP predictions for breast fibrosis rates following GammaPod and APBI treatments were 0.2 ± 0.1% vs. 2.8 ± 0.8% (p<0.001), respectively. Conclusions: The GammaPod system improves upon traditional post-lumpectomy linac-based APBI by decreasing dose to the ipsilateral breast as well as the predicted rates of breast fibrosis.